NHS & Hospitals
Supporting Reliable Medicine Supply Across UK Healthcare
Crescent Pharma supplies generic medicines to NHS hospitals and healthcare providers across the UK, supported by the wider development, manufacturing, quality, regulatory, supply chain and distribution capabilities of Crescent Pharmaceutical Group. Our approach is built around the priorities that matter to NHS procurement: patient safety, product quality, regulatory compliance, continuity of supply, supply chain resilience, sustainability and long-term value for healthcare providers.
Through continued investment in UK pharmaceutical infrastructure, global in-house development and manufacturing, strategic manufacturing partnerships and substantial UK medicine stockholding, we are strengthening the resilience and capacity required to support the changing needs of the NHS.
Our UK operations are complemented by Crescent's global in-house development and manufacturing capabilities and carefully selected strategic partners, providing additional capacity, flexibility and supply resilience.
Supporting NHS & Hospital Procurement
Crescent has an established presence within the UK hospital medicines market, with over 100 contracted hospital product lines, supported by substantial pharmaceutical operations and continued investment across the UK.
Our NHS supply capability is underpinned by UK pharmaceutical manufacturing, Quality Assurance, Quality Control, Regulatory Affairs, strategic medicine stockholding, warehousing and licensed pharmaceutical distribution. Across our UK operations, we continue to invest in manufacturing facilities, technology, infrastructure and distribution capacity to strengthen the resilience of medicine supply.
Together with our wider global capabilities, this provides the quality, capacity, flexibility and resilience required to support dependable medicine supply to NHS and hospital customers.
UK Manufacturing
Crescent continues to invest in pharmaceutical manufacturing operations across the UK, providing domestic capability across multiple dosage forms and supporting greater flexibility within our wider manufacturing network.
UK Quality & Regulatory Expertise
UK Quality Assurance, Quality Control and Regulatory Affairs capabilities support medicines supplied to NHS and hospital customers, reinforcing patient safety, product quality and regulatory compliance.
Strategic UK Stockholding
Substantial medicine inventories held within the UK provide an important layer of supply chain resilience, helping Crescent respond to changing demand and reduce exposure to disruption across international supply routes.
National Distribution Infrastructure
Continued investment in UK pharmaceutical warehousing and distribution, including our National Distribution Centre in Sheffield, strengthens the infrastructure supporting medicine supply across the country.
Building Resilience into UK Medicine Supply
Continuity of supply is fundamental to our approach to supporting NHS and hospital customers.
Crescent combines UK pharmaceutical infrastructure, strategic stockholding, diversified sourcing and coordinated supply planning to strengthen medicine availability and operational resilience.
Our UK operations are supported by global in-house manufacturing and carefully selected strategic manufacturing partners, creating additional supply routes and reducing unnecessary reliance on individual manufacturing sites or sources.
Strategic UK Stockholding
Substantial medicine inventories held within the UK provide an important buffer against fluctuations in demand, manufacturing disruption and international supply chain challenges.
Diverse Sourcing Strategy
Where appropriate, alternative manufacturing and sourcing routes are developed to reduce single-source dependency and strengthen supply chain resilience and business continuity.
Demand & Supply Planning
Forecasting, procurement, manufacturing, inventory and distribution activities are coordinated to support medicine availability and respond effectively to changing customer demand.
Additional Manufacturing Resilience
UK operations are complemented by global in-house manufacturing and qualified strategic manufacturing partners, providing additional capacity, flexibility and alternative supply options where required.
Investing in the Future of UK Medicine Supply
Crescent's National Distribution Centre in Sheffield represents a major investment in the future capacity and resilience of our UK pharmaceutical supply chain.
The facility provides substantial pharmaceutical storage capacity supported by temperature-controlled operations, modern warehouse management technology and semi-automated infrastructure.
Combined with our wider UK warehousing network and strategic stockholding approach, this infrastructure strengthens Crescent's ability to manage significant medicine inventories and support reliable distribution to healthcare customers across the UK.
Our continued investment in pharmaceutical warehousing and distribution provides additional capacity, control and flexibility as our portfolio and customer requirements continue to develop.
Quality, Patient Safety & Regulatory Compliance
Quality and patient safety underpin every medicine Crescent supplies. Our pharmaceutical operations are supported by established Quality Assurance, Quality Control and Regulatory Affairs functions providing appropriate oversight throughout the product lifecycle and pharmaceutical supply chain.
Crescent operates across a regulated network incorporating our own pharmaceutical operations together with qualified external development and manufacturing partners. Appropriate quality and regulatory oversight is maintained across these arrangements in accordance with applicable requirements.
Our continued investment in pharmaceutical quality systems, technology, infrastructure and specialist expertise supports:
- Patient safety and product quality
- Good Manufacturing Practice (GMP)
- Good Distribution Practice (GDP)
- Quality Assurance and Quality Control
- Regulatory compliance and product lifecycle management
- Supplier and manufacturing oversight
Expanding Choice for NHS & Hospital Customers
Continued Investment in Our Medicines Portfolio
Crescent continues to invest significantly in expanding its pharmaceutical portfolio and future product pipeline. Across Crescent Pharmaceutical Group, our development model combines global in-house pharmaceutical development, UK and global manufacturing capabilities, product acquisition and carefully selected contract development and manufacturing partners.
This provides multiple routes through which medicines can be developed, transferred, manufactured and introduced to the UK market. Continued portfolio expansion supports our long-term objective of increasing the range of high-quality generic medicines available to NHS and hospital customers, contributing to competition, choice and sustainable value within the UK medicines market.
Working with NHS Procurement Teams
A Long-Term Approach to Healthcare Supply
Our commercial and operational teams support NHS procurement organisations and hospital customers across tender requirements, forecasting, product availability, supply planning and ongoing account management, with appropriate support from Supply Chain, Quality and Regulatory Affairs.
We recognise that successful hospital medicine supply extends beyond product and price. Our approach is based on reliability, transparency, responsiveness and sustainable long-term value.
Responding to Changing Healthcare Needs
Capability When Demand Changes
Medicine demand and supply conditions can change rapidly. Crescent has previously worked with the Department of Health and Social Care during periods of exceptional national demand. Our ability to draw upon UK operations, global manufacturing, strategic manufacturing partners, procurement capability and substantial medicine inventories provides greater flexibility when responding to changing healthcare requirements.
These capabilities form part of our wider commitment to medicine availability, security of supply and the resilience of the UK’s pharmaceutical supply chain.
Supporting a More Sustainable NHS Supply Chain
Crescent recognises that environmental sustainability and social value are increasingly important considerations within NHS procurement.We are working to reduce the environmental impact associated with our operations and pharmaceutical supply chain while continuing to prioritise patient safety, product quality and security of supply.
Energy & Carbon Reduction
Improving energy efficiency and reducing the environmental impact of our operations.
Responsible Sourcing
Working across pharmaceutical sourcing and supplier engagement to support responsible procurement and resilient supply chains.
Transport & Logistics
Improving freight consolidation, vehicle utilisation and distribution efficiency where practicable.
Packaging & Waste
Identifying opportunities to reduce packaging and waste where compatible with regulatory requirements, product quality and patient safety.
UK Infrastructure
Continuing to invest in efficient UK manufacturing, warehousing and distribution infrastructure as part of our long-term operating strategy.Our approach is supported by our Carbon Reduction Plan and wider environmental and social governance framework. We recognise that NHS sustainability requirements will continue to develop and are committed to progressing our approach alongside those expectations.
Built to Support Long-Term UK Medicine Supply
Crescent’s continued investment in UK manufacturing, pharmaceutical development, quality and regulatory capability, strategic medicine stockholding and national distribution infrastructure reflects our long-term commitment to supporting NHS and hospital customers.
These UK capabilities, complemented by our global in-house operations and carefully selected strategic partners, provide the quality, capacity, flexibility and resilience required to support dependable medicine supply.
NHS & Hospital Enquiries
For NHS procurement, hospital pharmacy, tender or commercial enquiries relating to Crescent medicines, please contact our team.
Existing customers should continue to contact their Crescent sales representative through their established account channels.